Enhanced expression of cyclooxygenase-2 in high grade human transitional cell bladder carcinomas.
about
Combination of celecoxib with percutaneous radiotherapy in patients with localised prostate cancer - a phase I studyAlterations in lipoxygenase and cyclooxygenase-2 catalytic activity and mRNA expression in prostate carcinomaNon-steroidal anti-inflammatory drugs in the treatment of genitourinary malignancies: focus on clinical data.Cytotoxic necrotizing factor from Escherichia coli induces RhoA-dependent expression of the cyclooxygenase-2 Gene.Animal model of naturally occurring bladder cancer: characterization of four new canine transitional cell carcinoma cell lines.FGFR1-induced epithelial to mesenchymal transition through MAPK/PLCγ/COX-2-mediated mechanisms.Cyclooxygenase 2 selective inhibitors in cancer treatment and prevention.Expression of cyclooxygenase-2 in human transitional cell carcinoma of the urinary bladderDisruption of prostaglandin E2 receptor EP4 impairs urinary concentration via decreasing aquaporin 2 in renal collecting ducts.Expression of Prostacyclin-Synthase in Human Breast Cancer: Negative Prognostic Factor and Protection against Cell Death In VitroCyclooxygenase-2 expression in bladder cancer and patient prognosis: results from a large clinical cohort and meta-analysis.Urothelial tumorigenesis: a tale of divergent pathways.Long-term NSAID use and incident urothelial cell carcinoma in the VITamins and Lifestyle (VITAL) study.More than structural cells, fibroblasts create and orchestrate the tumor microenvironment.Cytochrome P450 interactions in human cancers: new aspects considering CYP1B1.COX-2 expression is associated with an aggressive phenotype in ductal carcinoma in situ.Cyclo-oxygenase-2 and its inhibition in cancer: is there a role?Inflammation and cancer: how friendly is the relationship for cancer patients?Chemoprevention in bladder cancer: What's new?The current state of head and neck cancer gene therapy.Management of upper urinary tract urothelial carcinoma.Systematic review and meta-analysis of COX-2 expression and polymorphisms in prostate cancer.Study of arachidonic Acid pathway in human bladder tumor.Clinical and prognosis relevance of COX-2 expression in Tunisian patients with primary gastric adenocarcinoma.Adenovirus-mediated IL-24 confers radiosensitization to human lung adenocarcinoma in vitro and in vivo.Reciprocal correlation between the expression of cyclooxygenase-2 and E-cadherin in human bladder transitional cell carcinomas.Photoperiod alters the time course of brain cyclooxygenase-2 expression in Siberian hamsters.Prostacyclin synthase: upregulation during renal development and in glomerular disease as well as its constitutive expression in cultured human mesangial cells.COX2/mPGES1/PGE2 pathway regulates PD-L1 expression in tumor-associated macrophages and myeloid-derived suppressor cells.Cyclooxygenase-2 and survivin in superficial urothelial carcinoma of the bladder and correlation with intratumoural microvessel density.Influence of cigarette smoking on prostaglandin synthesis and cyclooxygenase-2 gene expression in human urinary bladder cancer.Cyclooxygenase-2 promotes angiogenesis in pTa/T1 urothelial bladder carcinoma but does not predict recurrence.Arterial stiffness induces remodeling phenotypes in pulmonary artery smooth muscle cells via YAP/TAZ-mediated repression of cyclooxygenase-2.Differences in expression of uroplakin III, cytokeratin 7, and cyclooxygenase-2 in canine proliferative urothelial lesions of the urinary bladder.Cyclooxygenase-2 expression increases with the stage and grade in transitional cell carcinoma of the urinary bladder.Overexpression of CDC91L1 (PIG-U) in bladder urothelial cell carcinoma: correlation with clinical variables and prognostic significance.Cyclooxygenase-2 expression in astrocytomas. Relationship with microvascular parameters, angiogenic factors expression and survival.Inflammatory gene mRNA expression in human peripheral blood and its association with colorectal cancer
P2860
Q28218423-2DB8D33D-9CA3-4034-9D93-F1A00E1AF64CQ28360358-B7BB4329-004A-455E-A791-6C0B4F84DE31Q33304363-8E2513F8-F897-4163-872C-A8B270CB09DFQ33552763-0837891E-F540-4F1B-AD07-D672BD08715FQ33849066-2B2C2A17-C264-4543-84E9-F16352595A91Q34305855-26CA2FF8-BE8A-456A-BEAE-618AAD07BE01Q35011895-E3001665-F120-40B0-8A40-833ED4B9400CQ35746418-56736697-E37F-42DC-8531-69527BDCD97AQ35845853-5C01BCC2-2C1B-493A-A067-585519336F10Q35920285-E557DA39-4822-4775-928F-F7BF1819A4C3Q36232504-2F15ED8F-0912-4F94-BEFC-CE42A38557A2Q36234720-852AE4AF-BBED-4A64-B813-762FE6C70922Q36468046-16A2EBE5-54CD-4E5D-9AF5-F8BD800BEAE0Q36568993-686406F4-5F4B-4931-A856-0C203AD05CC9Q36572566-43A2E92B-F05D-4F11-939A-260D2DE8924FQ36694470-BE77FA92-D5EB-4F3F-92B1-5509E9743B4DQ36788347-5E8C3A48-8DC5-4A50-B598-1BDA4383CE7EQ37316105-5A7F54CB-B335-4712-B2B8-170960EAFADCQ37472582-1F77AA46-C44D-4ADD-AB96-7F745B5083A9Q37595513-EF956757-62DD-40C0-8D3D-512EFA6FAC28Q37812609-9EAFC544-9DDC-4427-BF8C-A7FA7E2044F7Q38051084-8B698D72-0892-4CC5-88EE-AD320FD92245Q38172928-5F63CDAB-E0B3-44D6-8913-D2957799ADAAQ38901848-A437A3F3-4765-4F27-A7E8-C747BD7356C2Q38931872-3F6C5530-8CD4-4877-8C60-BE4A50AFD8F0Q39687686-A9F37843-031B-4C6D-9C10-EB05FAFBBFBCQ40550652-6834BF5A-D91E-402A-8113-23285F9A68C4Q42183828-AEDB8977-5CB1-4716-AA24-7D64DA31527CQ42323954-B8429F71-B667-4187-9D8A-86E549CCA1CDQ43672969-FA7C9075-A12A-4051-A715-0A7FA249AD9FQ44115420-3E398DF8-4D00-49A9-8B8E-5437ADCE6931Q47675077-71596C00-0BA5-482D-8392-F6591D8830D2Q47993375-9194FDD0-5B58-406A-AAC9-96F446FE4ACDQ53093929-2103C252-74B3-42F7-BAF7-E40BFF1E1753Q53354820-3FD22176-1B34-4905-B71D-AE6BF2627B01Q53521507-DA1A92AD-5338-43B8-BEB7-AE03542AA3F3Q55469726-F451714E-6607-4BF8-B72C-9F58A7ABF631Q57070511-6C6D30D0-EAAC-46BD-B0F4-DF0709A5EDE1
P2860
Enhanced expression of cyclooxygenase-2 in high grade human transitional cell bladder carcinomas.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
2000年论文
@zh
2000年论文
@zh-cn
name
Enhanced expression of cycloox ...... ional cell bladder carcinomas.
@ast
Enhanced expression of cycloox ...... ional cell bladder carcinomas.
@en
type
label
Enhanced expression of cycloox ...... ional cell bladder carcinomas.
@ast
Enhanced expression of cycloox ...... ional cell bladder carcinomas.
@en
prefLabel
Enhanced expression of cycloox ...... ional cell bladder carcinomas.
@ast
Enhanced expression of cycloox ...... ional cell bladder carcinomas.
@en
P2093
P2860
P1476
Enhanced expression of cycloox ...... ional cell bladder carcinomas.
@en
P2093
H W Shappell
M D Breyer
S B Shappell
P2860
P356
10.1016/S0002-9440(10)64513-0
P407
P577
2000-07-01T00:00:00Z